Assembly Biosciences Inc. (NASDAQ: ASMB) announced that Phase 1b clinical data for two herpes simplex virus drug candidates will be ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE